Can we determine a threshold level for allergenic foods by statistical analysis of published data in the literature?
Patients with food allergies (1) always face the risk of allergic reactions by inadvertent intake of the offending food(s). In very sensitive patients, minute amounts may elicit severe reactions -systemic reactions to micrograms of food have been reported (2, 3) . Furthermore, food production is becoming increasingly complex, with several different food products being made in the same facility, which carries the risk of cross-contamination of allergenic compounds (4) . Labelling of foods is therefore a central measure to avoid allergic reactions in susceptible individuals. However, no hard data exist on a possible threshold dose of contamination below which no allergic patient is likely to experience symptoms, and therefore a zero level is currently used. Industry has responded with a proliferation of precautionary labeling (''may contain peanut'')-an approach which must be used with caution, only when appropriate, and not for legislative reasons.
Without available data on a threshold dose for a specific food, it is neither possible to conduct risk assessments nor to focus quality control on efforts which bring the greatest benefit to the allergic consumer. If different foods really do demonstrate different thresholds, then this problem is further increased for example, the lowest eliciting dose of milk is different (higher) than that of peanut.
At a conference held in South Carolina, USA in 1999, scientists focused on the lowest eliciting dose of an allergenic food. This data demonstrated that the lowest doses are probably in the microgram range, with large differences between various foods (5).
Presently there is no agreement on a common procedure for performing food challenges. Differences in such procedures add to the difficulties in comparing studies. In addition, it is often difficult to obtain a sufficiently large number of patients to base risk assessment calculations on, as many studies use very low numbers of subjects.
The aim of this paper was to investigate, using data from published studies, whether a statistical model could be developed to estimate a ''threshold'' dose that is, a dose which elicits allergic reactions in a given proportion of susceptible patients.
Material and methods
A MEDLINE survey on clinical trials using open food challenges (OFC), single-blind challenges (SBFC) or double-blind, placebo-controlled food challenges (DBPCFC) was first conducted and yielded 414 publications. After reading the publications, 25 papers were selected based on the availability of dose-response data and a suitable number of patients. These data were compiled and used for the subsequent analyses. Data on children and adults were included, as were all types of immediate allergic reactions.
A cumulative distribution function (plotting cumulative number of reacting patients against log dose) was used to model this type of dose-response data. A survival analysis approach was then taken to fit a mathematical equation to the log-transformed data, with a normal distribution function being used to model the shape of the curve. Confidence intervals were then calculated and subsequently added to this curve (which can be interpreted as a dose-response curve). The threshold, as defined in this paper, is the lower confidence limit on the dose that results in an allergic response in a given proportion of the studied population. This idea is very close in concept to the ''benchmark dose'' approach to calculating toxicity ''thresholds'' as developed by Crump (6) . In this paper, results are presented for a one-per-million response rate, as well as a one-perhundred response rate. Taking the lower confidence limit partly accounts for the experimental and protocol variability inherent in this type of analysis.
The allergen content of different foods varies for example, the protein fraction of cow's milk only constitutes 3.6 %, which corresponds to 36 mg of allergen per gram of milk. However, defatted soy flour contains mostly allergenic proteins (7, 8) .
Furthermore, different sources of food were used for challenge, i.e. freeze-dried food, de-fatted food or whole unprocessed food. Therefore, in order to enable comparisons between the different trials, a conversion from the actual food used in the trial to a calculated content of allergen was subsequently performed. A literature search revealed that for cow's milk, hen's egg, peanut and soy, quantitative data for allergen content was available, and so these four foods were chosen for subsequent analysis. These represented 68 published papers on milk, 48 on egg, 33 on peanut, and 33 on soy Table 2 . Table 2 presents the publications generated by the MEDLINE search, together with the number of publications where sufficient dose-response data were available. Both dose-response data and data on the quantitative allergen content were available for only milk, egg, peanut and soy, therefore these four foods were investigated further. Regarding celery and carrot, one well-conducted trial of each has recently been published (9, 10) but quantitative data on allergen content in celery or carrot are not available and therefore these studies are not included. Regarding hazelnut, one large-scale multicentre trial has been conducted that included dose-response investigations, but the data were published as mean values, so this investigation was not used (11) .
Results
An example of the type of model fitted to some doseresponse data, for each of the four foods, is presented in Fig. 1(A) . The x-axis represents the (log of) amount of food in the preparation actually used in the study, while the y-axis represents the cumulative proportion of responders. For the studies presented in Fig. 1(A) , the lower confidence limit associated with a one-per-million response rate (referred to hereafter as the ''threshold dose'') was calculated to be 0.046, 0.001, 0.0023 and 2279 mg for milk, egg, peanut and soy, respectively.
In Fig. 1(B) , the amount of food actually used in the separate trials was converted to calculated allergen content, and the studies were pooled within each food ''type'' (here, therefore, ''dose'' means the amount of allergen protein). Based on these pooled data, the calculated threshold values for the allergenic protein were 7.1r10
, and 0.3 mg, for milk, egg, peanut and soy, respectively. Table 3 shows the predicted dose and the lower confidence limit (threshold) for two different proportions of the susceptible population (one in a hundred and one in a million) giving positive responses for each food. This conversion to calculated allergen content allows for direct comparisons between the different foods. As can be seen, after conversion the threshold values for egg, milk and peanut are within a factor of 100, whereas that obtained for soy is higher (Table 4) The conversion from allergen intake back to food intake is shown in Table 4 . The lower threshold for egg and peanut corresponds well to the clinical finding that allergies to peanut and egg are usually more severe than to milk and soy. Again, the threshold values for egg, milk and peanut are within a factor of 100, whereas that obtained for soy is higher.
Finally, Fig. 2 demonstrates the curve fitted to all data, for all studies included and for all four foods combined. The resulting predicted threshold giving a one-in-a-million response rate is 7r10 x4 mg with the lower confidence interval being 1.8r10 x4 mg. By conversion back to the weight of actual food, this would represent 0.005 mg of cow's milk, 0.002 mg of fresh hen's egg, 0.0007 mg of peanut or 0.0013 mg of soy (made up weight). Based on these thresholds, it can be seen that the egg, milk and peanut thresholds are within a factor of 10, whilst soy is one order of magnitude higher. If a response rate of one in a hundred is examined, the threshold values are found to be 8.6 mg, 3.4 mg, 1.2 mg and 2.2 mg for milk, egg, peanut and soy flour, respectively. 
Discussion
In this paper a threshold dose has been defined as that which elicits an allergic reaction in a given proportion of the patients included in the analysis. Based on published data, we were able to create a dose-response curve which enabled determination of such a threshold dose. Determination of a common threshold dose for the four foods studied was enabled by conversion from the amount of food used for the actual challenges to an estimation of the actual allergen content in the preparation, and then using this value as the dose administered to the patients. This conversion revealed that the allergen thresholds of egg, milk and peanut are of the same magnitude (higher for soy). It also shows that the previously published differences found in threshold doses of different foods can be largely eliminated by comparing actual allergen content, which varies from 3.6 % in milk to 95 % per cent in de-fatted soy flour. This model may serve as the basis for further studies. There are however, several limitations to our approach. Firstly, the true threshold dose may be lower than calculated for two reasons: 1) the most sensitive patients presenting case histories of severe reactions to very minute amounts of the offending food are excluded from most clinical studies 2) in all trials included in this study, a number of patients reacted to the first administered dose ( Table 1 ), implying that the lowest dose eliciting a response for these subjects would be lower than the lowest dose tested.
Both the exclusion of the most sensitive patients from challenge and the inclusion of patients reacting to the first dose will result in overestimation, and therefore too high a threshold. The true thresholds for this sensitive subpopulation may thus be lower than the values presented here, although by taking the lower confidence limit some conservatism is built into the approach. A no observed effect level (NOEL), below which no patients will experience a reaction, also cannot be determined, due to the inclusion of patients who react to the first administered dose.
Furthermore, there are other limitations in our approach, requiring precaution when interpreting the findings: 1) We compared different trials using different protocols. To make this approach feasible we had to assume that children and adults react identically. We also had to assume that there were no significant differences in certain parameters, such as the inclusion criteria for different patients, the symptoms, the food source, the dose used for the first challenge, doseincrement protocol, time between doses, top dose, and interpretation of a positive result (12) , together with the fate of patients reacting to placebo challenges in the blinded protocols (13) . Such an assumption must be Threshold levels for allergenic foods (a) (b) Figure 1 used with caution. Furthermore, we also assumed that the presence of the expected amounts of allergens in the preparations and that all the known allergens in a particular food were of equal importance to all patients but this may not always be true. 4) In the calculations we assumed that the natural variability of the protein content was zero. This is especially not true for soy, where the allergen content may vary by up to two-fold depending on where it is grown (14) , and it may account for the different results obtained for soy compared to the other foods.
Despite these limitations, we have demonstrated for the first time an approach which may be helpful both to manufacturers and to government bodies who responsible for producing guidelines for risk assessment, and for subsequent legislation in this field.
In order to verify and substantiate the model, particularly to determine the thresholds with increased accuracy, the following approach is recommended: 1) Compiling raw data from various well-conducted clinical trials in collaboration with the original authors of these studies. Contact with the relevant individuals is in progress.
2) Development of a standardized challenge protocol to be used by all investigators in future trials. Such a protocol must ensure a sufficiently low starting dose for the challenge to avoid patients who react to the first dose.
3) Subsequently, prospective multicentre trials, that fulfil the above criteria, should be conducted using different foods in order to verify or discard the model. This work is currently being finalized under the auspices of the European Academy of Allergy and Clinical Immunology.
